논문KCI 등재
New Oral Anticoagulants versus Warfarin for Cerebral Venous Thrombosis: A Multi-Center, Observational Study
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
주제분류신경과학
초록
.
Abstract
.
참고문헌 (12)
- Luo Y, "Diagnosis and treatment of cerebral venous thrombosis: a review", Front Aging Neurosci, 10, pp.2~ (2018)
- Einhäupl KM, "Heparin treatment in sinus venous thrombosis", Lancet, 338, pp.597~600 (1991)
- Nagaraja D, "Randomized controlled trial of heparin in puerperal cerebral venous", sinus thrombosis, 1995, pp.13, 111~115
- de Bruijn SF, "Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis", Stroke, 30, pp.484~488 (1999)
- Linkins LA, "Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis", Ann Intern Med, 139, pp.893~900 (2003)
- Fang MC, "Death and disability from warfarin-associated intracranial and extracranial hemorrhages", Am J Med, 120, pp.700~705 (2007)
- Chai-Adisaksopha C, "The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and metaanalysis", Blood, 124, pp.2450~2458 (2014)
- Hon SF, "Use of direct thrombin inhibitor for treatment of cerebral venous thrombosis", J Stroke Cerebrovasc Dis, 21, pp.915.e11~915.e15 (2012)
- Rao SK, "Apixaban for the treatment of cerebral venous thrombosis: a case series", J Neurol Sci, 381, pp.318~320 (2017)
- Anticoli S, "Treatment of cerebral venous thrombosis with rivaroxaban", J Biomedical Sci, 5, pp.3~ (2016)
- Mendonça MD, "Oral direct thrombin inhibitor as an alternative in the management of cerebral venous thrombosis: a series of 15 patients", Int J Stroke, 10, pp.1115~1118 (2015)
- Ferro JM, "Rationale, design, and protocol of a randomized controlled trial of the safety and efficacy of dabigatran etexilate versus dose-adjusted warfarin in patients with cerebral venous thrombosis", Int J Stroke, 13, pp.766~770 (2018)
관련 논문AI추천
Prevalence and Associations of Dural Arteriovenous Fistulae in Cerebral Venous Thrombosis: Analysis of ACTION-CVTAaron Rothstein, Aaron Shoskes, Adeel S. Zubair, Alexis Simpkins, Ava Liberman, Charles Esenwa, David S. Liebeskind, Eva Mistry, Grace Li, Jacques J. Morcos, James E. Siegler, James Giles, Jennifer Frontera, Jordan Amar, Jose G. Romano, Kateryna Antonenko, Lindsey Kuohn, Liqi Shu, Marios Psychogios, Marwa ElNazeir, Mirjam R. Heldner, Mohamad Abdalkader, Negar Asdaghi, Nils Henninger, Ossama Khazaal, Piers Klein, Pooja Khatri, Richa Sharma, Robert M. Starke, Sami Al Kasab, Setareh Salehi Omran, Shadi Yaghi, Thalia Field, Thanh N. Nguyen, Yasmin Aziz대한뇌졸중학회 · 대한뇌졸중영문학회지2024 · 제26권 제2호Non-Vitamin K Oral Anticoagulants in Stroke Patients: Practical IssuesDavid S Liebeskind, Monica Khunger, UCLA, Los Angeles, United States대한뇌졸중학회 · 대한뇌졸중영문학회지2017 · 제19권 제1호Paradoxical Procoagulant Effect of Early Doses of Warfarin: Possible Role of Non-Vitamin K Oral Anticoagulant in Patients with Atrial Fibrillation-Related Stroke방오영, Yesel Kim대한뇌졸중학회 · 대한뇌졸중영문학회지2015 · 제17권 제2호Anticoagulation versus Antiplatelet Therapy after Ischemic Stroke in the Patients with Atrial Fibrillation and Cerebral MicrobleedsChangho Lee, Jae-Myung Kim, Ja-Hae Kim, Joon-Tae Kim, Kang-Ho Choi, Ki-Hyun Cho, Kyung-Wook Kang, Man-Seok Park, Seong-Min Choi대한뇌졸중학회 · 대한뇌졸중영문학회지2021 · 제23권 제2호Impact of Stroke Severity and Vascular Risk Factors on Early Versus Late Anticoagulation in Patients With Stroke and Atrial FibrillationAdhiyaman Vedamurthy, Alexander Salerno, Caterina Kulyk, Daniel Strbian, David Seiffge, Dimitri Hemelsoet, Gerli Sibolt, Hisanao Akiyama, Jesse Dawson, Jochen Vehoff, Kanta Tanaka, Kazunori Toyoda, Kosuke Matsuzono, Makoto Nakajima, Manabu Inoue, Manju Krishnan, Marjaana Tiainen, Martina Goeldlin, Masafumi Ihara, Masatoshi Koga, Mattia Branca, Peter Slade, Shigeru Fujimoto, Silja Räty, Sohei Yoshimura, Takenobu Kunieda, Takeshi Yoshimoto, Thomas Horvath, Urs Fischer, Yasuyuki Iguchi, Yusuke Yakushiji대한뇌졸중학회 · 대한뇌졸중영문학회지2025 · 제27권 제2호Timing and Predictors of Recanalization After Anticoagulation in Cerebral Venous ThrombosisAdeel S. Zubair, Alexis N. Simpkins, Allison Chang, Arsany Hakim, David S. Liebeskind, Eric D. Goldstein, Liqi Shu, Maria Cristina Vedovati, Maurizio Paciaroni, Mirjam R. Heldner, Neal S. Parikh, Piers Klein, Sami Al Kasab, Setareh Salehi Omran, Shadi Yaghi, Shawna Cutting, Thanh Nguyen대한뇌졸중학회 · 대한뇌졸중영문학회지2023 · 제25권 제2호
이 간행물의 다른 논문 (13건)
Asymptomatic Cerebral Small Vessel Disease: Insights from Population-Based StudiesRobert W. Regenhardt, Deborah Blacker, Meike W. Vernooij, Alvin S. Das, Andreas Charidimou, Anand Viswanathanapp. 121-138Effects of Thiazolidinedione and New Antidiabetic Agents on StrokeChang Ho Ahn, Soo Limpp. 139-150Gut Microbiota and Ischemic Stroke: The Role of Trimethylamine N-OxideHyo Suk Nampp. 151-159tPA Helpers in the Treatment of Acute Ischemic Stroke: Are They Ready for Clinical Use?Jong S. Kimpp. 160-174Family History, Tobacco Smoking, and Risk of Ischemic StrokeMengyu Fan, Canqing Yu, Zheng Bian, Yiping Chen, Zhengming Chen, Liming Li, Songchun Yang, Yaoming Zhai, Junshi Chen, Feifei Li, Ping Wang, Ling Yang, Lu Qi, Jun Lv, Yu Guopp. 175-183
